Klinger Shannon Thyme bought MRNA
March 2, 2026 · Form 4 insider transaction
Klinger Shannon Thyme bought 13,885 shares of Moderna, Inc. at $30.96 per share, a transaction worth $429.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
13,885
Price
$30.96
Total value
$429.9K
InsiderKlinger Shannon Thyme
Role—
CompanyModerna, Inc. (MRNA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after73,574
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025.